Defective antigen presentation by lavage cells from terminal patients with cystic fibrosis

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 542-547

  Knight, R A ^a,b   Kollnberger, S ^a   Madden, B ^a   Yacoub, M ^a   Hodson, M E ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b Emmanuel Kaye Building ^*  (United Kingdom)

Author keywords

Alveolar macrophages; Cystic fibrosis; Lymphocyte proliferation

Indexed keywords

ANTIGEN PRESENTATION; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPH NODE CELL; MONOCYTE; PRIORITY JOURNAL;

EID: 0031041037     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-954.x     Document Type: Article

References (27)

1. Knutzsen AP, Mueller KR. T cell cytotoxicity in cystic fibrosis; relationship to pulmonary status. Int Arch Allergy Appl Immunol 1990; 93:54-58.
2. Lahat N, Rivlin J, Iancu TC. Functional immunoregulatory abnormalities in cystic fibrosis patients. J Clin Immunol 1989; 9: 287-95.
3. Sorensen RU. Immune responses to Pseudomonas and other bacteria. In: Shapira E, Wilson GB, eds. Immunological aspects of cystic fibrosis. Boca Raton: CRC Press, 1984:101-23.
4. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med. 1994; 150:448-54.
5. Toews GB, Vial WC, Dunn MM, Guzzetta P, Nunez G, Stastny P, Lipscomb MF. Accessory cell function of human alveolar macrophages in specific cell proliferation. J Immunol 1984; 132:181-6.
6. Venet A, Hance AJ, Saltini C, Robinson BWS, Crystal RG. Enhanced alveolar macrophage-mediated antigen-induced T lymphocyte proliferation in sarcoidosis. J Clin Invest 1985; 75:293-301.
7. Spiteri MA, Poulter LW. Characterisation of immune inducer and suppressor macrophages from the normal human lung. Clin Exp Immunol 1991; 83:157-62.
8. Holt PG, Oliver J, Bilyk N, McMenamin C, McMenamin PG, Kraal G, Thepen T. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993; 177:397-407.
9. Chelen CJ, Fang Y, Freeman GJ et al. Human alveolar macrophages present antigen ineffectively due to detective expression of B7 costimulatory molecules. J Clin Invest 1995; 95:1415-21.
10. Ferro TJ, Monos DS, Spear BT, Rossman MD, Zmijewski CM, Kamoun M, Daniele RP. Carbohydrate differences in HLA-DR molecules synthesised by alveolar macrophages and blood monocytes. Am Rev Respir Dis 1987; 135:1340-4.
11. Meyer KC, Powers C, Rosenthal N, Auerbach R. Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles. Am Rev Respir Dis 1993; 148:1325-34.
12. Ettensohn DB, Duncan PG, Jankowski MJ. The role of human alveolar macrophages in the allogeneic and autologous mixed leucocyte reactions. Clin Exp Immunol 1989; 75:432-7.
13. Weissler JC, Lyons CR, Lipscomb MF, Toews GB. Human pulmonary macrophages. Functional comparison of cells obtained from whole lung and by bronchoalveolar lavage. Am Rev Respir Dis 1986; 133: 473-7.
14. Nibbering PH, Van der Heide A, Van Furth R. Macrophages in bronchoalveolar lavage fluid are not representative of macrophages in granulomas of the lungs of BCG-infected mice. J Pathol 1989; 157:253-61.
15. Vecchiarelli A, Pietrella D, Dottorini M, Monari C, Retini C, Todisco T, Bistoni F. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin Exp Immunol 1994; 98:217-23.
16. Ettensohn DB, Jankowski MJ, Duncan PG, Buckley KD. Density-defined subpopulations of human alveolar macrophages differ in their ability to stimulate a mixed leukocyte reaction and autologous mixed leukocyte reaction. Am Rev Respir Dis 1988; 137:38A.
17. Holt PG. Pulmonary dendritic cell populations. Adv Exp Med Biol 1993; 329:557-62.
18. Gong JL, McCarthy KM, Telford J, Tamatani T, Miyasaka M, Schneeberger EE. Intraepithelial airway dendritic cells: a distinct subset of pulmonary dendritic cells obtained by microdissection. J Exp Med 1992; 175:797-807.
19. Holt PG, Oliver J, Bilyk N, McMenamin PG, Kraal G, Thepen T. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993; 177:397-407.
20. Goldstein W, Doring G. Lysosomal enzymes and proteinase inhibitors in the sputum of patients with cystic fibrosis. Am Rev Respir Dis 1986; 134:49-56.
21. Tosi MF, Zakem H, Berger M. Neutrophil elastase cleaves C3bi on opsonised Pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990; 86:300-8.
22. Berger M, Sorensen RU, Tosi MF. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest 1989; 84:1302-13.
23. Doring G, Frank K, Boudier C, Herbert S, Fleischer B, Bellon G. Cleavage of lymphocyte surface antigens CD2, CD4 and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J Immunol 1995; 154:4842-50.
24. Sorensen RU, Klinger JD. Biological effects of P. aeruginosa phenacine pigments. In: Doring G, Holder IA, Botzenhart K, eds. Basic research and clinical aspects of Pseudomonas aeruginosa. Antibiot Chemother 1987; 39:113-24.
25. Rich EA, Tweardy DJ, Fujiwara H, Ellner JJ. Spectrum of immuno-regulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis 1987; 136:258-65.
26. Mitchell DM, Fitzharris P, Knight RA, Schild GC. Kinetics of specific in vitro antibody production following influenza immunisation. Clin Exp Immunol 1982; 48:491-7.
27. Winnie GB, Cowan RG. Respiratory tract colonisation with Pseudomonas aeruginosa in cystic fibrosis: correlation between anti-Pseudomonas aeruginosa antibody levels and pulmonary function. Pediatr Pulmonol 1991; 10:92-100.